Commentary: Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and CHIP Reauthorization Act of 2015.

MLA

Barbieri, John S., et al. “Commentary: Future Considerations for Clinical Dermatology in the Setting of 21st Century American Policy Reform: The Medicare Access and CHIP Reauthorization Act of 2015.” Journal of the American Academy of Dermatology, vol. 76, no. 6, June 2017, pp. 1203–05. EBSCOhost, https://doi.org/10.1016/j.jaad.2017.01.033.

APA

Barbieri, J. S., Miller, J. J., Nguyen, H. P., Forman, H. P., Bolognia, J. L., VanBeek, M. J., & Group for Research of Policy Dynamics in Dermatology. (2017). Commentary: Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and CHIP Reauthorization Act of 2015. Journal of the American Academy of Dermatology, 76(6), 1203–1205. https://doi.org/10.1016/j.jaad.2017.01.033

Chicago

Barbieri, John S., Jeffrey J. Miller, Harrison P. Nguyen, Howard P. Forman, Jean L. Bolognia, Marta J. VanBeek, and Group for Research of Policy Dynamics in Dermatology. 2017. “Commentary: Future Considerations for Clinical Dermatology in the Setting of 21st Century American Policy Reform: The Medicare Access and CHIP Reauthorization Act of 2015.” Journal of the American Academy of Dermatology 76 (6): 1203–5. doi:10.1016/j.jaad.2017.01.033.